4 months in and hepatic fat is still the thing I get wrong
4 months in and hepatic fat is still the thing I get wrong, logged the same way every week so the comparison is at least internally fair. The numbers the title promised, since a headline without them is worthless: 4 months. Everything below is context for those. It is a dual agonist at the GLP-1 and glucagon…
Agreed that the endpoint definitions matter enormously and almost nobody reads them before quoting a response rate.
Independent purity results for this compound are very sparse across the whole site, which means any impression about consistency is built on almost nothing.
the titration in the trials was slow and deliberate
Biopsy-confirmed population or imaging-selected?
Which phase and which arm are you quoting?
Removed the escalation schedule. Unapproved compound, no protocols for other members, no exceptions.